Increasing Investments by Key Players Are Driving the Growth of the Global Commercial Aircraft Market

Commercial Aircraft Market
Commercial Aircraft Market

Commercial Aircraft Market, By Aircraft Type (Narrow-body Aircraft, Wide-body Aircraft, and Regional Aircraft), By Engine Type (Turbofan and Turboprop), By Application (Passenger Aircraft and Freighter) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030.

Market Overview:

A commercial aircraft refers to an aircraft that is used for commercial purposes, primarily for transporting passengers or cargo. These aircraft are typically operated by airlines or air carriers and are designed to provide safe and efficient transportation for commercial air travel.

Commercial aircraft are specifically designed and built to meet the requirements of commercial air transportation, including passenger comfort, operational efficiency, and safety standards. They are subject to stringent regulations and certifications to ensure compliance with aviation authorities and international standards.

Competitive Landscape:

Major players operating in the global Commercial Aircraft Market include Mitsubishi Aircraft Corporation, Commercial Aircraft Corporation of China Ltd., ATR, ROSTEC, Embraer SA, The Boeing Company, and Airbus SE.

Key Market Drivers:

The rising middle-class population, growing urbanization, and increasing disposable incomes have led to a surge in air travel demand. The demand for commercial aircraft is driven by the need to cater to the growing passenger traffic and facilitate regional and international connectivity. This is expected to augment the growth of the global commercial aircraft for market.

The Commercial Aircraft Market was estimated at USD 96.8 billion in 2021, and from 2022 to 2030, it is projected to increase at a compound annual growth rate (CAGR) of 5.3%.

Airlines worldwide are expanding their fleets to meet the growing demand for air travel. Fleet modernization initiatives and the replacement of older aircraft with newer, more fuel-efficient models are driving the market. For instance, in July 2022, Porter Airlines placed an order for 20 Embraer E195-E2s, for their expansion plan.

Ongoing advancements in aircraft design, engine efficiency, lightweight materials, and avionics are enhancing the performance, fuel efficiency, and passenger experience of commercial aircraft. These technological advancements are estimated to enhance the growth of the global Commercial Aircraft Market.

Covid-19 Impact Analysis:

The COVID-19 pandemic has had a severe impact on the global commercial aircraft for market. The travel restrictions, lockdown measures, and decline in air travel demand led to grounded fleets, reduced passenger traffic, and financial challenges for airlines. The pandemic also disrupted the global supply chain, causing delays in aircraft deliveries and order cancellations. However, with the gradual reopening of economies and increasing vaccination rates, air travel is expected to recover, driving the market's resurgence.

Key Takeaways:

· North America is expected to dominate the growth of the global commercial aircraft for market, owing to the presence of major aircraft manufacturers, such as Boeing and Airbus. The region has a mature aviation industry, high air travel demand, and large fleet size, contributing to market growth. For instance, in August 2022, Boeing invested around US$ 5 million in a St. Louis facility, in order to accelerate advanced manufacturing innovations.

· The Asia Pacific is estimated to witness high growth in the global Commercial Aircraft Market. Factors such as increasing air travel demand, expanding middle-class population, rising urbanization, and the emergence of low-cost carriers contribute to market growth. For instance, in June 2022, Airbus and Qantas invested around US$ 200 million in order to aid the development of sustainable aviation fuel.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more